UNRESECTABLE ESOPHAGEAL SQUAMOUS CELL CARCINOMA

Clinical trials for UNRESECTABLE ESOPHAGEAL SQUAMOUS CELL CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new UNRESECTABLE ESOPHAGEAL SQUAMOUS CELL CARCINOMA trials appear

Sign up with your email to follow new studies for UNRESECTABLE ESOPHAGEAL SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Cancer care comes home: mayo clinic tests At-Home immunotherapy shots

Disease control Recruiting now

This study is testing whether giving a cancer immunotherapy treatment called nivolumab as an injection at home is a safe and practical alternative to receiving it at a clinic. It aims to see if home treatment reduces the burden of travel and improves quality of life for patients …

Matched conditions: UNRESECTABLE ESOPHAGEAL SQUAMOUS CELL CARCINOMA

Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control

Last updated Mar 16, 2026 15:27 UTC

UNRESECTABLE ESOPHAGEAL SQUAMOUS CELL CARCINOMA

Get alerted when new UNRESECTABLE ESOPHAGEAL SQUAMOUS CELL CARCINOMA trials appear

Cancer care comes home: mayo clinic tests At-Home immunotherapy shots